The aim of the KidneySign project is to develop and validate non-invasive biomarkers for kidney fibrosis and CKD progression. The project relies on the participation of patients in previous cohort studies and in a prospective observational clinical study.

By identifying patients at lower or higher risk of CKD progression, the new biomarkers would greatly improve CKD management for both patients and doctors. Patients at high risk of progression will benefit from a more tightly monitoring and nephroprotective therapies, while patients are low risk who receive the the standard of care can be reassured on their health.

The KidneySign project also gives a lot of importance to the patients' vision of health and medicine, that is captured by questionnaires and interviews. 

If you would like to share your perspectives on health and medicine, you are invited to contact the KidneySign research team (kidneysign@rd-n.org).

Acknowledgements